A carregar...
Effects of renal impairment on the pharmacokinetics of orally administered deferiprone
AIMS: In light of the growing recognition of renal disease in thalassemia, it is important to understand the impact of renal impairment on the pharmacokinetics of iron chelators. This study evaluated the pharmacokinetics and safety of the iron chelator deferiprone (DFP) in subjects with renal impair...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5137824/ https://ncbi.nlm.nih.gov/pubmed/27276421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13037 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|